NanoVibronix Regains Nasdaq Compliance
NanoVibronix Regains Nasdaq Compliance
NanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on November 20, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the minimum stockholders' equity requirement of $2.5 million. Accordingly, the previously disclosed listing matter has been closed.
生产UroShield和PainShield 表面声波（SAW）便携式超声治疗设备的医疗器械公司NanoVibronix, Inc.（纳斯达克股票代码：NAOV）（以下简称 “公司”）今天宣布，2023年11月20日，公司收到纳斯达克股票市场有限责任公司的正式通知，该公司已证明符合继续在纳斯达克资本市场上市的所有适用标准，包括2.5美元的最低股东权益要求百万。因此，此前披露的上市事项已经结案。